131 related articles for article (PubMed ID: 8228281)
1. Carrier determination for X-linked agammaglobulinemia using X inactivation analysis of purified B cells.
Alterman LA; de Alwis M; Genet S; Lovering R; Middleton-Price H; Morgan G; Jones A; Malcolm S; Levinsky RJ; Kinnon C
J Immunol Methods; 1993 Nov; 166(1):111-6. PubMed ID: 8228281
[TBL] [Abstract][Full Text] [Related]
2. Application of carrier testing to genetic counseling for X-linked agammaglobulinemia.
Allen RC; Nachtman RG; Rosenblatt HM; Belmont JW
Am J Hum Genet; 1994 Jan; 54(1):25-35. PubMed ID: 7506482
[TBL] [Abstract][Full Text] [Related]
3. Carrier detection in agammaglobulinemia by X chromosome inactivation analysis.
Miyashita T; Iwata T; Mizutani S; Kamoshita S; Kobayashi N
Acta Paediatr Jpn; 1992 Jun; 34(3):267-72. PubMed ID: 1354911
[TBL] [Abstract][Full Text] [Related]
4. Carrier detection in typical and atypical X-linked agammaglobulinemia.
Conley ME; Puck JM
J Pediatr; 1988 May; 112(5):688-94. PubMed ID: 2896233
[TBL] [Abstract][Full Text] [Related]
5. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
6. Carrier identification in X-linked immunodeficiency diseases.
Li SL; Ting SS; Lindeman R; Ffrench R; Ziegler JB
J Paediatr Child Health; 1998 Jun; 34(3):273-9. PubMed ID: 9633977
[TBL] [Abstract][Full Text] [Related]
7. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.
Futatani T; Watanabe C; Baba Y; Tsukada S; Ochs HD
Br J Haematol; 2001 Jul; 114(1):141-9. PubMed ID: 11472359
[TBL] [Abstract][Full Text] [Related]
8. A PCR based X-chromosome inactivation assay for carrier detection in X-linked immunodeficiencies using differential methylation of the androgen receptor gene.
Schmucker B; Meindl A; Achatz H; Mittermüller J; Krüger G; Hergersberg M; Spiegel R; Schinzel A; Belohradsky BH; Murken J
Immunodeficiency; 1995; 5(3):187-92. PubMed ID: 7749438
[TBL] [Abstract][Full Text] [Related]
9. A PCR-based non-radioactive X-chromosome inactivation assay for genetic counseling in X-linked primary immunodeficiencies.
Wengler GS; Parolini O; Fiorini M; Mella P; Smith H; Ugazio AG; Notarangelo LD
Life Sci; 1997; 61(14):1405-11. PubMed ID: 9335230
[TBL] [Abstract][Full Text] [Related]
10. Carrier detection and prenatal diagnosis of X-linked agammaglobulinemia.
Journet O; Durandy A; Doussau M; Le Deist F; Couvreur J; Griscelli C; Fischer A; de Saint-Basile G
Am J Med Genet; 1992 Jul; 43(5):885-7. PubMed ID: 1642281
[TBL] [Abstract][Full Text] [Related]
11. Physical mapping identifies DXS265 as a useful genetic marker for carrier detection and prenatal diagnosis of X-linked agammaglobulinemia.
Lovering R; Sweatman AK; O'Reilly MA; Genet SA; Middleton-Price H; Malcolm S; Levinsky RJ; Kinnon C
Hum Genet; 1993 Mar; 91(2):178-80. PubMed ID: 8462977
[TBL] [Abstract][Full Text] [Related]
12. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation.
Fearon ER; Winkelstein JA; Civin CI; Pardoll DM; Vogelstein B
N Engl J Med; 1987 Feb; 316(8):427-31. PubMed ID: 2880293
[TBL] [Abstract][Full Text] [Related]
13. X chromosome inactivation patterns in haematopoietic cells of female carriers of X-linked severe combined immunodeficiency determined by methylation analysis at the hypervariable DXS255 locus.
Hendriks RW; Kraakman ME; Schuurman RK
Clin Genet; 1992 Sep; 42(3):114-21. PubMed ID: 1395081
[TBL] [Abstract][Full Text] [Related]
14. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
15. X chromosome inactivation analysis to distinguish sporadic cases of X-linked agammaglobulinaemia from common variable immunodeficiency.
Tsuge I; Matsuoka H; Abe T; Kamachi Y; Torii S
Eur J Pediatr; 1993 Nov; 152(11):900-4. PubMed ID: 8276019
[TBL] [Abstract][Full Text] [Related]
16. X-linked agammaglobulinemia.
Timmers E; de Weers M; Alt FW; Hendriks RW; Schuurman RK
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S83-93. PubMed ID: 1934617
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
[TBL] [Abstract][Full Text] [Related]
18. A novel Tth111I restriction fragment length polymorphism (RFLP) allows tracing of X-chromosome inactivation in the (Xid) heterozygote.
Shanmugam V; Chapman VM; Sell KW; Saha BK
Biochem Genet; 1996 Feb; 34(1-2):17-29. PubMed ID: 8935990
[TBL] [Abstract][Full Text] [Related]
19. Evidence for failure of V(D)J recombination in bone marrow pre-B cells from X-linked agammaglobulinemia.
Schwaber J
J Clin Invest; 1992 Jun; 89(6):2053-9. PubMed ID: 1602011
[TBL] [Abstract][Full Text] [Related]
20. Improved HUMARA for the Detection of X-Linked Agammaglobulinemia Carriers.
Carrillo-Tapia E; Espinosa-Padilla SE; Perez-Perez D; Gonzalez-Serrano ME; Berron-Ruiz L; Espinosa-Rosales FJ; Rodriguez-Alba JC; Mújica-Guzman F; Yokoyama-Rebollar E; García-Flores JR; Herrera-González NE; Scheffler-Mendoza S; Yamazaki-Nakashimada MA; Staines-Boone AT; Lopez-Herrera G
Genet Test Mol Biomarkers; 2022 Apr; 26(4):220-227. PubMed ID: 35394812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
